FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Peptide Reclassification 2026: What It Actually Means Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA's Overreach on Compounded Peptides FDA Unbans 14 Peptides for Legal US Compounding! : r Biohackers